Dakin, Helen; Sherman, Morris; Fung, Scott; Fidler, Carrie - In: PharmacoEconomics 29 (2011) 12, pp. 1075-1091
<Emphasis Type="Bold">Introduction: Previous research has demonstrated that tenofovir disoproxil fumarate (DF) is the most cost-effective nucleos(t)ide treatment for chronic hepatitis B (CHB) in the UK, Spain, Italy and France. However, to our knowledge, no published studies have yet evaluated the cost effectiveness...</emphasis>